Glenmark Pharmaceuticals Ltd - ADR

GREY:GLKQY (India)   ADR
$ 0.00 0 (0%) 09:42 AM EST
At Loss
P/B:
5.18
Volume:
-
Avg Vol (2M):
-
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
-

Business Description

Description
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe, and the rest of the world.
Name Current Vs Industry Vs History
Cash-To-Debt 1.15
Equity-to-Asset 0.55
Debt-to-Equity 0.21
Debt-to-EBITDA 0.96
Interest Coverage 2.61
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.17
Distress
Grey
Safe
Beneish M-Score -3.24
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.46
Quick Ratio 1
Cash Ratio 0.33
Days Inventory 208.34
Days Sales Outstanding 79.66
Days Payable 177.43

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 7.91

Financials (Next Earnings Date:2025-02-14 Est.)

GLKQY's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with GREY:GLKQY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Glenmark Pharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0.58
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 0
Shares Outstanding (Mil) 282.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Glenmark Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Glenmark Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Glenmark Pharmaceuticals Ltd Frequently Asked Questions

What is Glenmark Pharmaceuticals Ltd(GLKQY)'s stock price today?
The current price of GLKQY is $0.00. The 52 week high of GLKQY is $0.00 and 52 week low is $0.00.
When is next earnings date of Glenmark Pharmaceuticals Ltd(GLKQY)?
The next earnings date of Glenmark Pharmaceuticals Ltd(GLKQY) is 2025-02-14 Est..
Does Glenmark Pharmaceuticals Ltd(GLKQY) pay dividends? If so, how much?
Glenmark Pharmaceuticals Ltd(GLKQY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1